About The Medical Condition BRL26921
Find the definition of the medical term BRL26921. BRL26921 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
BRL26921
| BRL26921 Medical Condition |
|---|
What's The Definition Of The Medical Condition BRL26921?
An acylated inactive complex of streptokinase and human lysine-plasminogen. After injection, the acyl group is slowly hydrolyzed, producing an activator that converts plasminogen to plasmin, thereby initiating fibrinolysis. Its half-life is about 90 minutes compared to 5 minutes for TPA; (TISSUE PLASMINOGEN ACTIVATOR); 16 minutes for URINARY PLASMINOGEN ACTIVATOR and 23 minutes for STREPTOKINASE. If treatment is initiated within 3 hours of onset of symptoms for acute myocardial infarction, the drug preserves myocardial tissue and left ventricular function and increases coronary artery patency. Bleeding complications are similar to other thrombolytic agents.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Intraoral Photography ‐ Photographic techniques used in orthodontics, aesthetic dentistry,…
- Cerebellar Syndromes, Paraneoplastic ‐ Cerebellar degeneration associated with a remote neoplasm. Clinical…
- Cytotaxins ‐ Chemical substances that attract or repel cells or organisms.…
- Seizures, Subclinical ‐ Conditions characterized by recurrent paroxysmal neuronal discharges…
- Intraocular Lens ‐ Artificial…
- Soybean Proteins ‐ Proteins which are present in or isolated from…
- Pupil Disorders ‐ Conditions which affect the structure or function of the pupil…
- Dicrocoeliasis ‐ Infection with flukes of the genus…
- Immunolabeling Techniques ‐ Histochemical localization of immunoreactive substances using…
- Infections, Bunyaviridae ‐ Virus diseases caused by the…